Literature DB >> 29860984

Cancer Navigation Strategy for Endocrine Therapy-Resistant Breast Tumors.

Mitsuyoshi Nakao1, Saori Fujiwara2, Hirotaka Iwase3.   

Abstract

Estrogen receptor (ER) α-positive breast cancers frequently acquire resistance to endocrine therapy. However, recent studies found that a fraction of these tumors overexpress ER, and that estrogen treatment induces apoptosis. We propose a 'cancer navigation' strategy to systematically lead resistant cells to growth arrest and apoptosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; ESR1 gene; endocrine resistance; estrogen receptor; estrogen-induced apoptosis

Mesh:

Substances:

Year:  2018        PMID: 29860984     DOI: 10.1016/j.trecan.2018.04.005

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  2 in total

Review 1.  Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy.

Authors:  Xiaonan Zhang; Tobias Sjöblom
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-13

2.  COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer.

Authors:  Qi Luo; Jinsui Li; Xiaohan Su; Qiao Tan; Fangfang Zhou; Shaoli Xie
Journal:  Front Genet       Date:  2022-09-09       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.